Multiple Epigenetic Mechanisms Functionally Cooperate to Silence Expression of Somatostatin Receptor Type 2 in Pancreatic Neuroendocrine Tumors. This evidence concerns the gene SSTR2 and pancreatic neuroendocrine tumor.